RecruitingNCT07473375
Indicators Affecting PVT Recanalization
Indicators Affecting Portal Vein Thrombosis Recanalization in Cirrhosis With Gastroesophageal Varices
Sponsor
Shanghai Zhongshan Hospital
Enrollment
1,500 participants
Start Date
Jan 1, 2017
Study Type
OBSERVATIONAL
Conditions
Summary
This is a retrospective-prospective study conducted at Zhongshan Hospital, Fudan University, to explore portal vein thrombosis (PVT) in patients with cirrhosis and gastroesophageal varices (GEV). It aimed to provide insights into the diagnosis, follow-up, and factors influencing PVT recanalization, to help patients, families, and healthcare providers understand the disease and related clinical management.
Eligibility
Min Age: 18 YearsMax Age: 80 Years
Inclusion Criteria2
- diagnosed as cirrhosis and confirmed gastroesophageal varices by endoscopy;
- all patients were diagnosed as PVT by CTA at admission.
Exclusion Criteria5
- patients with hepatocellular carcinoma;
- patients with extrahepatic malignancies;
- history of liver transplantation or TIPS;
- lack of information regarding anticoagulation therapy；
- those with cavernous transformation of the portal vein(CTPV) .
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07473375
Related Trials
Biannual Screening for HCC Offered to Patients With Cirrhosis. Introducing Surveillance for Hepatocellular Carcinoma (HCC) in the Central Denmark Region Using Ultrasound and Alpha-Fetoprotein to Reduce HCC-Related Mortality in Patients With Compensated Non-Viral Cirrhosis
NCT074693196 locations
FAST-IRM for HCC suRveillance in pAtients With High risK of Liver Cancer.
NCT050957141 location
Remote Electrical Stimulation for Pain and Depression Treatment in Cirrhosis
NCT069327831 location
Prevalence of Gastric Motor Dysfunction and Upper GI Symptoms in Gastric Antral Vascular Ectasias
NCT063069631 location
Hepatic Venous Pressure Gradient Versus Endoscopic Ultrasound-Guided Portal Pressure Gradient - Comparative Analysis (HEPCA)
NCT074249632 locations